Forteo and Localised oedema - a phase IV clinical study of FDA data

Summary:

Localised oedema is reported as a side effect among people who take Forteo (teriparatide recombinant human), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Prevacid, and have Insomnia.

The phase IV clinical study analyzes which people have Localised oedema when taking Forteo. It is created by eHealthMe based on reports of 126,656 people who have side effects when taking Forteo from the FDA, and is updated regularly.

What is Forteo?

Forteo has active ingredients of teriparatide recombinant human. It is often used in osteoporosis. eHealthMe is studying from 127,076 Forteo users. Check the latest studies of Forteo.

What is Localised oedema?

Localised oedema (fluid retention in a particular part of the body) is found to be associated with 553 drugs and 707 conditions by eHealthMe. Check the latest studies of Localised oedema.

On Jul, 10, 2026

126,656 people reported to have side effects when taking Forteo.
Among them, 47 people (0.04%) have Localised oedema.

Among these 47 people:

How long have people been on Forteo when they have Localised oedema? *

What is the gender of people who have Localised oedema when taking Forteo? *

female: 91.49 %
male: 8.51 %

What is the age of people who have Localised oedema when taking Forteo? *

What are other drugs people take besides Forteo? *

What are other side effects people have besides Localised oedema? *

Oedema Peripheral (superficial swelling): 18 people, 38.30%
Pain: 11 people, 23.40%
Injection Site Pain: 10 people, 21.28%
Joint Pain: 9 people, 19.15%
Pain In Extremity: 8 people, 17.02%
Joint Swelling: 7 people, 14.89%
Hypotension (abnormally low blood pressure): 7 people, 14.89%
Abdominal Pain: 6 people, 12.77%
Weakness: 6 people, 12.77%
Fatigue (feeling of tiredness): 5 people, 10.64%

What are the existing conditions these people have? *

Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 6.38%
Nausea (feeling of having an urge to vomit): 3 people, 6.38%
Insomnia (sleeplessness): 3 people, 6.38%
Asthma: 2 people, 4.26%
Hypersensitivity: 2 people, 4.26%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 4.26%
Pain: 1 person, 2.13%
Heart Rate Increased: 1 person, 2.13%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 2.13%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 2.13%

* Approximation only. Some reports may have incomplete information.

Do you take Forteo and have Localised oedema?

- Check whether Localised oedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Forteo:

Forteo (127,076 reports)

Localised oedema treatments and more:

Localised oedema (5,668 reports)

How severe was Localised oedema and when was it recovered:

Localised oedema in Forteo

Expand to all the drugs that have ingredients of teriparatide recombinant human:

Localised oedema and drugs with ingredients of teriparatide recombinant human

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Forteo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Localised oedema:

Localised oedema (553 drugs)

Browse all the conditions that are associated with Localised oedema:

Localised oedema (707 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on teriparatide recombinant human (the active ingredients of Forteo) and Forteo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.